Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U01CA290663 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
The purpose of this study is to implement a clinic-level cancer survivorship care delivery intervention in partnership with community health center clinicians, patients, and community representatives to test effectiveness of the intervention to improve patient and clinician outcomes and to evaluate implementation of the intervention using an iterative, concurrent mixed-methods approach guided by the Practice Change Model.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Step 1 (2 clinics)-6 months control then 12 months intervention | Experimental |
| |
| Step 2 (2 clinics)-12 months control then 12 months intervention | Experimental |
| |
| Step 3 (2 clinics)-18 months control then 12 months intervention | Experimental |
| |
| Step 4 (2 clinics)- 24 months control then 12 months intervention | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Survivorship care delivery intervention | Behavioral | Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:
|
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of eligible cancer survivors screened for second primary cancers | Data derived from electronic health records | every 6 months from baseline to end of study (about 36 months from baseline) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in proportion of primary care clinician knowledge of cancer survivorship care | Assessed by self-administered survey | baseline, six months following end of intervention period |
| Change proportion of survivors that report better experience of provider communication as assessed by the adapted Consumer Assessment of Healthcare Providers and Systems (CAHPS 4.0) |
Not provided
Inclusion Criteria (participants):
-at least one visit to the Community Health Centers (CHCs) in the prior year
Exclusion Criteria (participants):
- no history of cancer recorded in the problem list or past medical history in the medical record
Inclusion Criteria (clinicians):
-employed clinicians (e.g. physicians, nurses, pharmacists, or other allied health professionals) and non-clinician staff of the participating CHC clinics
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bijal Balasubramanian, MBBS, PhD | The University of Texas Health Science Center, Houston | Principal Investigator |
| Simon Craddock Lee, PhD | University of Kansas Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The University of Texas Health Science Center, Houston | Houston | Texas | 77030 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41454266 | Derived | Millett ME, Malthaner LQ, McCallister K, Craig DW, Eary R, Valerio-Shewmaker MA, Shay LA, Rajan SS, Ma HY, Ghosh S, Crabtree BF, Lee SJC, Balasubramanian BA. Community and Academic Synergy for Cancer Survivorship Care Delivery Enhancement (Project CASCADE): a study protocol for a pragmatic, stepped-wedge, cluster-randomized trial in Texas primary care community health centers. BMC Prim Care. 2025 Dec 27;27(1):18. doi: 10.1186/s12875-025-03108-1. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Stepped-wedge cluster randomized trial (SW-CRT). There will be 4 clusters (CHCs) having 2 practices each.
Not provided
Not provided
Not provided
Not provided
|
| baseline, six months following end of intervention period |
| Change proportion of survivors that report better experience of care coordination as assessed by the adapted Consumer Assessment of Healthcare Providers and Systems (CAHPS 4.0) | baseline, six months following end of intervention period |
| Proportion of survivors who received guideline-recommended surveillance for the most prevalent cancers (breast colorectal, prostate, cervical, and lung) | Per national guidelines [National Comprehensive Cancer Network (NCCN), U.S. Preventive Services Task Force (USPSTF)]; data derived from electronic health records | every 6 months from baseline to end of study (about 36 months from baseline) |